Basics of TGF-β and pancreatic cancer

Mark Truty, Raul Urrutia

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Pancreatic cancer is the 4th leading cause of cancer-related death in the United States. The number of diagnoses per year equals the number of deaths per year, making it the deadliest of all malignancies. Modern advances and breakthroughs in molecular oncology have allowed researchers to gain a better understanding of the mechanisms responsible for the pathogenesis of this disease. The transforming growth factor-β (TGF-β) pathway is one of the signaling systems that has been identified as a major contributor. TGF-β plays a paradoxical role as both a tumor suppressor and a tumor promoter in pancreatic cancer. The purpose of this review is to provide the practicing clinician a thorough review of this molecule and its associated signaling partners in the context of its duplicitous role and behavior in patients with pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)423-435
Number of pages13
JournalPancreatology
Volume7
Issue number5-6
DOIs
StatePublished - Oct 2007

Fingerprint

Transforming Growth Factors
Pancreatic Neoplasms
Neoplasms
Carcinogens
Research Personnel

Keywords

  • Pancreatic cancer
  • Signaling system
  • Transforming growth factor-β

ASJC Scopus subject areas

  • Endocrinology
  • Gastroenterology

Cite this

Basics of TGF-β and pancreatic cancer. / Truty, Mark; Urrutia, Raul.

In: Pancreatology, Vol. 7, No. 5-6, 10.2007, p. 423-435.

Research output: Contribution to journalArticle

Truty, Mark ; Urrutia, Raul. / Basics of TGF-β and pancreatic cancer. In: Pancreatology. 2007 ; Vol. 7, No. 5-6. pp. 423-435.
@article{47552ef0640a43b1acb74c4e8f1f1672,
title = "Basics of TGF-β and pancreatic cancer",
abstract = "Pancreatic cancer is the 4th leading cause of cancer-related death in the United States. The number of diagnoses per year equals the number of deaths per year, making it the deadliest of all malignancies. Modern advances and breakthroughs in molecular oncology have allowed researchers to gain a better understanding of the mechanisms responsible for the pathogenesis of this disease. The transforming growth factor-β (TGF-β) pathway is one of the signaling systems that has been identified as a major contributor. TGF-β plays a paradoxical role as both a tumor suppressor and a tumor promoter in pancreatic cancer. The purpose of this review is to provide the practicing clinician a thorough review of this molecule and its associated signaling partners in the context of its duplicitous role and behavior in patients with pancreatic cancer.",
keywords = "Pancreatic cancer, Signaling system, Transforming growth factor-β",
author = "Mark Truty and Raul Urrutia",
year = "2007",
month = "10",
doi = "10.1159/000108959",
language = "English (US)",
volume = "7",
pages = "423--435",
journal = "Pancreatology",
issn = "1424-3903",
publisher = "S. Karger AG",
number = "5-6",

}

TY - JOUR

T1 - Basics of TGF-β and pancreatic cancer

AU - Truty, Mark

AU - Urrutia, Raul

PY - 2007/10

Y1 - 2007/10

N2 - Pancreatic cancer is the 4th leading cause of cancer-related death in the United States. The number of diagnoses per year equals the number of deaths per year, making it the deadliest of all malignancies. Modern advances and breakthroughs in molecular oncology have allowed researchers to gain a better understanding of the mechanisms responsible for the pathogenesis of this disease. The transforming growth factor-β (TGF-β) pathway is one of the signaling systems that has been identified as a major contributor. TGF-β plays a paradoxical role as both a tumor suppressor and a tumor promoter in pancreatic cancer. The purpose of this review is to provide the practicing clinician a thorough review of this molecule and its associated signaling partners in the context of its duplicitous role and behavior in patients with pancreatic cancer.

AB - Pancreatic cancer is the 4th leading cause of cancer-related death in the United States. The number of diagnoses per year equals the number of deaths per year, making it the deadliest of all malignancies. Modern advances and breakthroughs in molecular oncology have allowed researchers to gain a better understanding of the mechanisms responsible for the pathogenesis of this disease. The transforming growth factor-β (TGF-β) pathway is one of the signaling systems that has been identified as a major contributor. TGF-β plays a paradoxical role as both a tumor suppressor and a tumor promoter in pancreatic cancer. The purpose of this review is to provide the practicing clinician a thorough review of this molecule and its associated signaling partners in the context of its duplicitous role and behavior in patients with pancreatic cancer.

KW - Pancreatic cancer

KW - Signaling system

KW - Transforming growth factor-β

UR - http://www.scopus.com/inward/record.url?scp=35348901453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348901453&partnerID=8YFLogxK

U2 - 10.1159/000108959

DO - 10.1159/000108959

M3 - Article

C2 - 17898532

AN - SCOPUS:35348901453

VL - 7

SP - 423

EP - 435

JO - Pancreatology

JF - Pancreatology

SN - 1424-3903

IS - 5-6

ER -